Boston Scientific (BSX) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance MeasuresZacks Investment Research • 01/30/26
Will Robust MedSurg Performance Fuel Boston Scientific's Q4 Earnings?Zacks Investment Research • 01/28/26
Boston Scientific (BSX) Exceeds Market Returns: Some Facts to ConsiderZacks Investment Research • 01/24/26
Polen Global Growth Portfolio Q4 2025 Performance, Attribution & Portfolio ActivitySeeking Alpha • 01/22/26
Down 6.3% in 4 Weeks, Here's Why Boston Scientific (BSX) Looks Ripe for a TurnaroundZacks Investment Research • 01/16/26
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN)GlobeNewsWire • 01/15/26
BSX Stock May Gain From Newly Inked Deal to Buy Valencia TechnologiesZacks Investment Research • 01/15/26
Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing' vascular segmentsMarket Watch • 01/15/26
Boston Scientific Corporation (BSX) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Boston Scientific Announces Agreement to Acquire Valencia Technologies CorporationPRNewsWire • 01/12/26
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?Zacks Investment Research • 01/08/26